TY - JOUR
T1 - Comprehensive analysis of antibody responses to streptococcal and tissue antigens in patients with acute rheumatic fever
AU - Martins, Thomas B.
AU - Hoffman, James I.
AU - Augustine, Nancy H.
AU - Phansalkar, Amit R.
AU - Fischetti, Vincent A.
AU - Zabriskie, John B.
AU - Cleary, Patrick P.
AU - Musser, James M.
AU - Veasy, L. George
AU - Hill, Harry R.
PY - 2008/3
Y1 - 2008/3
N2 - Acute rheumatic fever (ARF) is an autoimmune disease occurring in individuals following untreated group A streptococcal infection believed to be triggered by antibodies to bacterial components that cross-react with human tissues. We developed a multiplexed immunoassay for the simultaneous quantitation of antibodies to nine streptococcal-related antigens including streptolysin O (SLO), DNase B, collagen I and IV, fibronectin, myosin, group A carbohydrate, M6 protein and streptococcal C5a peptidase. Utilizing this method, we examined serum from 49 ARF, 58 pharyngitis patients and age- and sex-matched controls in samples collected at initial disease onset, and at 4 weeks, 6 months and 1 year after diagnosis. Antibody responses were significantly higher for SLO, DNase B, M6 protein, group A carbohydrate and the cross-reactive antigens collagen I and myosin in ARF compared with pharyngitis patients (P ≤ 0.05). Moreover, we found significantly elevated antibody responses in the ARF patients with rheumatic heart disease to fibronectin and collagen I compared with ARF patients without heart disease. The major differences between the ARF patients with and without carditis appear to be in the immune response to the putative heart valve components, collagen I and fibronectin.
AB - Acute rheumatic fever (ARF) is an autoimmune disease occurring in individuals following untreated group A streptococcal infection believed to be triggered by antibodies to bacterial components that cross-react with human tissues. We developed a multiplexed immunoassay for the simultaneous quantitation of antibodies to nine streptococcal-related antigens including streptolysin O (SLO), DNase B, collagen I and IV, fibronectin, myosin, group A carbohydrate, M6 protein and streptococcal C5a peptidase. Utilizing this method, we examined serum from 49 ARF, 58 pharyngitis patients and age- and sex-matched controls in samples collected at initial disease onset, and at 4 weeks, 6 months and 1 year after diagnosis. Antibody responses were significantly higher for SLO, DNase B, M6 protein, group A carbohydrate and the cross-reactive antigens collagen I and myosin in ARF compared with pharyngitis patients (P ≤ 0.05). Moreover, we found significantly elevated antibody responses in the ARF patients with rheumatic heart disease to fibronectin and collagen I compared with ARF patients without heart disease. The major differences between the ARF patients with and without carditis appear to be in the immune response to the putative heart valve components, collagen I and fibronectin.
KW - Acute rheumatic fever
KW - Antibody responses
KW - Cross-reactivity
KW - Group A streptococcus
KW - Molecular mimicry
KW - Multiplexed immunoassay
KW - Rheumatic heart disease
UR - http://www.scopus.com/inward/record.url?scp=40049101987&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=40049101987&partnerID=8YFLogxK
U2 - 10.1093/intimm/dxn004
DO - 10.1093/intimm/dxn004
M3 - Article
C2 - 18245783
AN - SCOPUS:40049101987
SN - 0953-8178
VL - 20
SP - 445
EP - 452
JO - International Immunology
JF - International Immunology
IS - 3
ER -